EA201000118A1 - SUBLINGUAL OR TRANSBUCKCAL COMPOSITIONS CONTAINING AMBER ACID AND INTENDED FOR THE TREATMENT OF ALZHEIMER'S DISEASE - Google Patents

SUBLINGUAL OR TRANSBUCKCAL COMPOSITIONS CONTAINING AMBER ACID AND INTENDED FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Info

Publication number
EA201000118A1
EA201000118A1 EA201000118A EA201000118A EA201000118A1 EA 201000118 A1 EA201000118 A1 EA 201000118A1 EA 201000118 A EA201000118 A EA 201000118A EA 201000118 A EA201000118 A EA 201000118A EA 201000118 A1 EA201000118 A1 EA 201000118A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sublingual
disease
alzheimer
transbuckcal
treatment
Prior art date
Application number
EA201000118A
Other languages
Russian (ru)
Inventor
Игорь Анатольевич Помыткин
Original Assignee
Игорь Анатольевич Помыткин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Игорь Анатольевич Помыткин filed Critical Игорь Анатольевич Помыткин
Publication of EA201000118A1 publication Critical patent/EA201000118A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к сублингвальной или трансбуккальной фармацевтической композиции, содержащей терапевтически эффективные количества янтарной кислоты или ее фармацевтически приемлемой соли, и фармацевтически приемлемый носитель. Далее, настоящее изобретение относится к методам предотвращения или лечения болезни Альцгеймера с использованием композиций настоящего изобретения.The present invention relates to a sublingual or buccal pharmaceutical composition comprising therapeutically effective amounts of succinic acid or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Further, the present invention relates to methods for preventing or treating Alzheimer's disease using the compositions of the present invention.

EA201000118A 2007-08-15 2007-08-15 SUBLINGUAL OR TRANSBUCKCAL COMPOSITIONS CONTAINING AMBER ACID AND INTENDED FOR THE TREATMENT OF ALZHEIMER'S DISEASE EA201000118A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2007/000446 WO2009025571A1 (en) 2007-08-15 2007-08-15 Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease

Publications (1)

Publication Number Publication Date
EA201000118A1 true EA201000118A1 (en) 2010-06-30

Family

ID=39429279

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000118A EA201000118A1 (en) 2007-08-15 2007-08-15 SUBLINGUAL OR TRANSBUCKCAL COMPOSITIONS CONTAINING AMBER ACID AND INTENDED FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Country Status (2)

Country Link
EA (1) EA201000118A1 (en)
WO (1) WO2009025571A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124061A (en) * 1991-04-01 1992-06-23 Geary Sr Robert J Systemic plant cryoprotection with choline salts
US20030147850A1 (en) * 2001-09-27 2003-08-07 Pomytkin Igor Anatolievich Composition and methods for potentiating therapeutic effects of interferons
AU2003291796A1 (en) * 2003-06-27 2005-01-13 Igor A. Pomytkin Synergistic compositions comprising erythropoietin and succinic acid (salt)
EP1765300A2 (en) * 2004-06-10 2007-03-28 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
RU2281766C1 (en) * 2005-03-04 2006-08-20 Игорь Анатольевич Помыткин Method for improving cognitive function

Also Published As

Publication number Publication date
WO2009025571A1 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
UA86614C2 (en) Compound having kinase ingibitor activity, pharmaceutical composition containing thereof and use thereof for the preparation of medicine
EA201101672A1 (en) SUBSTITUTED DERIVATIVES OF AMINOISAL ACID AS NEPRILISIN INHIBITORS
CY1117576T1 (en) NUCLEOTIC PRODUCTS
ATE517882T1 (en) QUINOLINE DERIVATIVES
BRPI0811280B8 (en) amino-heterocyclic compounds, pharmaceutical composition comprising them and uses of said compounds
UY30411A1 (en) SUBSTITUTED DERIVATIVES OF THE ACETATE OF 2,3,4, -TETRAHYDROIMIDAZO- [1,5-A] -PIRIMIDIN-6-AMINA, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
MXPA03011484A (en) Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.
CL2007002288A1 (en) COMPOUNDS DERIVED FROM CONDENSED IMIDAZOL-AMINA, INHIBITORS OF BETA-SECRETASA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT, PREVENTION OR IMPROVEMENT OF DISEASES SUCH AS ALZHEIMER'S DISEASE, DETERIORATION
EA201290191A1 (en) N1-PYRAZOLOSPIROKETONE INHIBITORS ACETYL-KoA-CARBOXYLASE
ATE554084T1 (en) N-HYDROXYACRYLAMIDE COMPOUNDS
TW200806299A (en) Treatment of pain
EA201101671A1 (en) SUBSTITUTED DERIVATIVES OF AMINOPROPIONIC ACID AS NEPRILISIN INHIBITORS
TW200639159A (en) Treatment of pain
EA200900152A1 (en) PYRROLOTRIAZINKINASE INHIBITORS
DE602005004286D1 (en) 5-AMINO-2,4,7-TRIOXO-3,4,7,8-TETRAHYDRO-2H-PYRIDOE2,3-DYPYRIMIDIN DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CANCER
MY177111A (en) Substituted amide derivatives and methods of use
EA201391720A1 (en) SUBSTITUTED DIOXOPIPERIDINYL-PHTHALIMIDE DERIVATIVES
EA200870577A1 (en) CONDENSED TRICYCLIC SULPHONAMIDE INHIBITORS GAMMA-SECRETASES
EA201100138A1 (en) 4-PHENOXYMETHYL-PIPERIDINES AS MODEL ACTIVITY GPR119
EA200970287A1 (en) METHODS, COMPOUNDS, COMPOSITIONS AND MEDIA SUITABLE FOR DELIVERY OF 3-AMINO-1-PROPANSULPHONE ACID
EA201270144A1 (en) COMBINED THERAPY FOR TREATMENT OF DIABETES
EA200702253A1 (en) PHARMACEUTICAL COMPOSITION
TW200626158A (en) Naphthaline derivatives
EA201171088A1 (en) TREATMENT OF DISKINESIA IN DIFFERENT DISORDERS
EA201070442A1 (en) NEW sEH INHIBITORS AND THEIR APPLICATION